Spiros Kotopoulis 5/25/22 Spiros Kotopoulis 5/25/22

DoMore Diagnostics achieves CE-IVD mark for Histotype Px® Colorectal, an AI algorithm that predict patient outcomes in colorectal cancer patients by analyzing standard histology images

Spiros Kotopoulis 5/9/22 Spiros Kotopoulis 5/9/22

DoMore Diagnostics congratulates Prof. Håvard Danielsen with the King Olav V´s Cancer Research Prize for 2022

DoMore Diagnostics congratulates Prof. Håvard Danielsen with the King Olav V´s Cancer Research Prize for 2022. The prestigious prize was handed over by HM Kong Harald V on behalf of the Norwegian Cancer Society in Oslo on May 9.

Spiros Kotopoulis 4/5/22 Spiros Kotopoulis 4/5/22

DoMore Diagnostics announces that Sophie Grindstad and Ole J. Dahlberg join as new members to the Board of Directors

DoMore Diagnostics announces that Sophie Grindstad and Ole J. Dahlberg have been elected as new members to the Board of Directors

Spiros Kotopoulis 1/28/22 Spiros Kotopoulis 1/28/22

DoMore Diagnostics announces the formation of our Scientific Advisory Board

World renowned experts joining the Scientific Advisory Board to support the development of DoMore Diagnostics

Spiros Kotopoulis 12/17/21 Spiros Kotopoulis 12/17/21

Watch the DoMore Diagnostics presentation at DNB NXT Venture Session

Spiros Kotopoulis 12/10/21 Spiros Kotopoulis 12/10/21

DoMore Diagnostics will present at DNB NXT Venture Session on December 16

Spiros Kotopoulis 11/25/21 Spiros Kotopoulis 11/25/21

The DoMore Diagnostics team will be present at the 8th Digital Pathology & AI conference in London on December 1 and 2

Spiros Kotopoulis 10/19/21 Spiros Kotopoulis 10/19/21

DoMore Diagnostics featured on the Radium Podcast

News & Events